Cargando…

Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats

OBJECTIVE: To evaluate the effect of curcumin on olanzapine-induced obesity in rats. MATERIALS AND METHODS: Sprague-Dawley (SD) rats were used for experiments. The animals were divided into six groups, namely, normal control, olanzapine control, betahistine (10 mg/kg), and curcumin 50, 100, and 200...

Descripción completa

Detalles Bibliográficos
Autores principales: Parasuraman, Subramani, Zhen, Khor Ming, Banik, Urmila, Christapher, Parayil Varghese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541480/
https://www.ncbi.nlm.nih.gov/pubmed/28827965
http://dx.doi.org/10.4103/pr.pr_8_17
_version_ 1783254815956008960
author Parasuraman, Subramani
Zhen, Khor Ming
Banik, Urmila
Christapher, Parayil Varghese
author_facet Parasuraman, Subramani
Zhen, Khor Ming
Banik, Urmila
Christapher, Parayil Varghese
author_sort Parasuraman, Subramani
collection PubMed
description OBJECTIVE: To evaluate the effect of curcumin on olanzapine-induced obesity in rats. MATERIALS AND METHODS: Sprague-Dawley (SD) rats were used for experiments. The animals were divided into six groups, namely, normal control, olanzapine control, betahistine (10 mg/kg), and curcumin 50, 100, and 200 mg/kg treated groups. Except the normal control group, all other animals were administered with olanzapine 4 mg/kg intraperitoneally to induce obesity. The drugs were administered once daily, per oral for 28 days. During the experiment, body weight changes and behavior alterations were monitored at regular intervals. At the end of the experiment, blood sample was collected from all the experimental animals for biochemical analysis. Part of the liver and kidney tissues was harvested from the sacrificed animals and preserved in neutral formalin for histopathological studies. RESULTS: Curcumin showed a significant reduction in olanzapine-induced body weight gain on the rats and improved the locomotor effects. The effect of curcumin on olanzapine-induced body weight gain is not comparable with that of betahistine. CONCLUSION: This study has shown metabolic alteration effect of curcumin on olanzapine, an antipsychotic drug, treated SD rats. SUMMARY: Olanzapine is an atypical antipsychotic drug used for the treatment of schizophrenia and bipolar disorder. Obesity is an adverse effect of olanzapine, and the present study was made an attempt to study the effect of curcumin on olanzapine-induced obesity in rats. In this present study, curcumin significantly reduced olanzapine-induced body weight gain in rats. Abbreviations Used: 5HT: 5-hydroxytryptamine, ALP: Alkaline phosphatase, ALT: Alanine transaminase, ANOVA: Analysis of variance, AST: Aspartate transaminase, CMC: Carboxymethyl cellulose, D: Dopamine, H and E: Hematoxylin and Eosin stain, H: Histamine, HDL-C: Highdensity lipoprotein cholesterol, IP: Intraperitoneal, MAO: Monoamine oxidase, NaOH: Sodium hydroxide, SD rats: Sprague Dawley rats, TCs: Total cholesterols, TG: Triglyceride. [Image: see text]
format Online
Article
Text
id pubmed-5541480
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-55414802017-08-21 Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats Parasuraman, Subramani Zhen, Khor Ming Banik, Urmila Christapher, Parayil Varghese Pharmacognosy Res Original Article OBJECTIVE: To evaluate the effect of curcumin on olanzapine-induced obesity in rats. MATERIALS AND METHODS: Sprague-Dawley (SD) rats were used for experiments. The animals were divided into six groups, namely, normal control, olanzapine control, betahistine (10 mg/kg), and curcumin 50, 100, and 200 mg/kg treated groups. Except the normal control group, all other animals were administered with olanzapine 4 mg/kg intraperitoneally to induce obesity. The drugs were administered once daily, per oral for 28 days. During the experiment, body weight changes and behavior alterations were monitored at regular intervals. At the end of the experiment, blood sample was collected from all the experimental animals for biochemical analysis. Part of the liver and kidney tissues was harvested from the sacrificed animals and preserved in neutral formalin for histopathological studies. RESULTS: Curcumin showed a significant reduction in olanzapine-induced body weight gain on the rats and improved the locomotor effects. The effect of curcumin on olanzapine-induced body weight gain is not comparable with that of betahistine. CONCLUSION: This study has shown metabolic alteration effect of curcumin on olanzapine, an antipsychotic drug, treated SD rats. SUMMARY: Olanzapine is an atypical antipsychotic drug used for the treatment of schizophrenia and bipolar disorder. Obesity is an adverse effect of olanzapine, and the present study was made an attempt to study the effect of curcumin on olanzapine-induced obesity in rats. In this present study, curcumin significantly reduced olanzapine-induced body weight gain in rats. Abbreviations Used: 5HT: 5-hydroxytryptamine, ALP: Alkaline phosphatase, ALT: Alanine transaminase, ANOVA: Analysis of variance, AST: Aspartate transaminase, CMC: Carboxymethyl cellulose, D: Dopamine, H and E: Hematoxylin and Eosin stain, H: Histamine, HDL-C: Highdensity lipoprotein cholesterol, IP: Intraperitoneal, MAO: Monoamine oxidase, NaOH: Sodium hydroxide, SD rats: Sprague Dawley rats, TCs: Total cholesterols, TG: Triglyceride. [Image: see text] Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5541480/ /pubmed/28827965 http://dx.doi.org/10.4103/pr.pr_8_17 Text en Copyright: © 2017 Pharmacognosy Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Parasuraman, Subramani
Zhen, Khor Ming
Banik, Urmila
Christapher, Parayil Varghese
Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats
title Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats
title_full Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats
title_fullStr Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats
title_full_unstemmed Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats
title_short Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats
title_sort ameliorative effect of curcumin on olanzapine-induced obesity in sprague-dawley rats
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541480/
https://www.ncbi.nlm.nih.gov/pubmed/28827965
http://dx.doi.org/10.4103/pr.pr_8_17
work_keys_str_mv AT parasuramansubramani ameliorativeeffectofcurcuminonolanzapineinducedobesityinspraguedawleyrats
AT zhenkhorming ameliorativeeffectofcurcuminonolanzapineinducedobesityinspraguedawleyrats
AT banikurmila ameliorativeeffectofcurcuminonolanzapineinducedobesityinspraguedawleyrats
AT christapherparayilvarghese ameliorativeeffectofcurcuminonolanzapineinducedobesityinspraguedawleyrats